Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EXCELSIOR

Financiado

Cerrado

The Expression of CXC chemokine ligand 4 in Systemic Sclerosis and its Role in t...

The Expression of CXC chemokine ligand 4 in Systemic Sclerosis and its Role in the regulation of immune and fibrotic responses Systemic sclerosis (SSc) is a chronic inflammatory disorder in which excessive fibrosis occurs in all vital organs, leading to profound disability and premature death. The pathogenesis of SSc is still unclear. Although earlier stu... ver más

02/07/2016

UMC UTRECHT

183K€

Presupuesto del proyecto: 183K€

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-07-02 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UMC UTRECHT

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CIRCUMVENT Closing in on Runx3 and CXCL4 to open novel avenues for ther... 2M€ Cerrado

ReKUPFFERate Investigating if recuperating hepatic macrophage numbers and... 176K€ Cerrado

Lung Fibrosis Investigating the role of the immune system in the developme... 239K€ Cerrado

SAF2014-57708-R INTERACCION BIDIRECCIONAL ENTRE LOS LINFOCITOS Y SU MICROAMB... 363K€ Cerrado

SAF2009-07100 FRECUENCIA, FENOTIPO Y FUNCION DE LAS CELULAS TH-17 EN LA AR... 157K€ Cerrado

RYC-2010-05920 Function of the tetraspanin family members, CD9 and CD81, du... 192K€ Cerrado

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 183K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Systemic sclerosis (SSc) is a chronic inflammatory disorder in which excessive fibrosis occurs in all vital organs, leading to profound disability and premature death. The pathogenesis of SSc is still unclear. Although earlier studies focused on fibroblast biology and pro-fibrotic factors, recently evidence advocates an important role of immune cells in the pathogenesis of this disease. In the last few years Prof. Radstake's has focused on immune cell subsets, in particular on plasmacytoid dendritic cells (pDCs), to identify their potential role in SSc. This has led to various landmark observations. Firstly, pDCs were found to secrete high amounts of specific chemokine-CXCL4. Secondly, CXCL4 was found to be closely associated with disease severity and implicated in key immune defects that recapitulate SSc. The current proposal builds further on these key observations and aims at elucidating the underlying mechanisms by which CXCL4 drives SSc by addressing three research topics: 1) identify factors that drive CXCL4 secretion, 2) discover novel functions of CXCL4, 3) determine the role of CXCL4 in vivo. For this purpose I will exploit patient material from a unique SSc cohort, use various state-of-the-art technologies and apply three experimental mouse models. SSc might be the ideal disease to study events that preclude the onset of fibrosis, since both the immune component and typical fibrotic events coincide in this condition. The state-of-the-art know-how, techniques and patient material present at the Laboratory of Translational Research ensure not only a fast and effective dissemination of our results to third parties (pharma) to initiate the development of therapeutic targets, but also the extrapolation to other fibrosing conditions such as idiopathic pulmonary fibrosis etc. Altogether, the current grant provides unique opportunities for me as researcher and research field to show that CXCL4 is an attractive therapeutic target for battling fibrosing conditions.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores